The 15-minute chart for Corbus has triggered a golden cross, as indicated by the KDJ indicator, alongside a bullish marubozu pattern observed on September 29, 2022, at 15:15. This indicates a shift in momentum towards an upward trajectory, suggesting that the stock price has the potential to continue increasing. The control of the market is currently held by buyers, and it is likely that the bullish momentum will persist.
Corbus Pharmaceuticals Holdings Inc. (CRBP) experienced a notable upturn in its stock price on September 29, 2022, despite a broader market downturn. The stock advanced by 5.38% to $12.14, outperforming some of its competitors. This rebound comes after a two-day losing streak, with the stock closing 47.96% short of its 52-week high of $23.33
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day[1].
The trading session was marked by a decline in the NASDAQ Composite Index (COMP) and the Dow Jones Industrial Average (DJIA), with the former falling 0.50% to 22,384.70 and the latter dropping 0.38% to 45,947.32. Despite this, CRBP managed to snap its losing streak and even exceeded its 50-day average trading volume of 123,286, with a volume of 134,222 shares traded
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day[1].
The 15-minute chart for CRBP has shown a significant technical indicator shift, triggering a golden cross as indicated by the KDJ indicator, alongside a bullish marubozu pattern observed on September 29, 2022, at 15:15. This suggests a potential upward trajectory for the stock, with the market currently favoring buyers .
Corbus Pharmaceuticals Holdings Inc. has also outperformed some of its competitors on the same day. Vanda Pharmaceuticals Inc. (VNDA) fell 1.43% to $4.83, Fortress Biotech Inc. (FBIO) rose 1.63% to $3.75, and Viking Therapeutics Inc. (VKTX) fell 5.78% to $25.09
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day[1].
Investors should monitor the ongoing momentum and technical indicators to gauge the stock's potential for further price appreciation. The current bullish signals and market conditions may suggest that CRBP could continue its upward trend.
Comments
No comments yet